Chesterfield A - Search Results

1

Meaning and role of functional-organic distinction: a study of clinicians in psychiatry and neurology services.

Chesterfield A, Harvey J, Hendrie C, Wilkinson S, Vera San Juan N, Bell V. Chesterfield A, et al. Med Humanit. 2024 Feb 22;50(1):170-178. doi: 10.1136/medhum-2023-012667. Med Humanit. 2024. PMID: 37968099

2

The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.

Watt ML, Rorick-Kehn L, Shaw DB, Knitowski KM, Quets AT, Chesterfield AK, McKinzie DL, Felder CC. Watt ML, et al. Among authors: chesterfield ak. Neuropsychopharmacology. 2013 Dec;38(13):2717-26. doi: 10.1038/npp.2013.186. Epub 2013 Aug 2. Neuropsychopharmacology. 2013. PMID: 23907402 Free PMC article.

3

Regulation of GPR119 receptor activity with endocannabinoid-like lipids.

Syed SK, Bui HH, Beavers LS, Farb TB, Ficorilli J, Chesterfield AK, Kuo MS, Bokvist K, Barrett DG, Efanov AM. Syed SK, et al. Among authors: chesterfield ak. Am J Physiol Endocrinol Metab. 2012 Dec 15;303(12):E1469-78. doi: 10.1152/ajpendo.00269.2012. Epub 2012 Oct 16. Am J Physiol Endocrinol Metab. 2012. PMID: 23074242 Free article.

4

Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.

Watt ML, Schober DA, Hitchcock S, Liu B, Chesterfield AK, McKinzie D, Felder CC. Watt ML, et al. Among authors: chesterfield ak. J Pharmacol Exp Ther. 2011 Aug;338(2):622-32. doi: 10.1124/jpet.111.182063. Epub 2011 May 10. J Pharmacol Exp Ther. 2011. PMID: 21558436

5

Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.

Suter TM, Chesterfield AK, Bao C, Schaus JM, Krushinski JH, Statnick MA, Felder CC. Suter TM, et al. Among authors: chesterfield ak. Eur J Pharmacol. 2010 Dec 15;649(1-3):44-50. doi: 10.1016/j.ejphar.2010.08.055. Epub 2010 Sep 17. Eur J Pharmacol. 2010. PMID: 20851117

6

Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.

Donohue SR, Krushinski JH, Pike VW, Chernet E, Phebus L, Chesterfield AK, Felder CC, Halldin C, Schaus JM. Donohue SR, et al. Among authors: chesterfield ak. J Med Chem. 2008 Sep 25;51(18):5833-42. doi: 10.1021/jm800416m. J Med Chem. 2008. PMID: 18800770 Free PMC article.

7

The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.

Yasuno F, Brown AK, Zoghbi SS, Krushinski JH, Chernet E, Tauscher J, Schaus JM, Phebus LA, Chesterfield AK, Felder CC, Gladding RL, Hong J, Halldin C, Pike VW, Innis RB. Yasuno F, et al. Among authors: chesterfield ak. Neuropsychopharmacology. 2008 Jan;33(2):259-69. doi: 10.1038/sj.npp.1301402. Epub 2007 Mar 28. Neuropsychopharmacology. 2008. PMID: 17392732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters